Business
Cali Fund falls far short of $1bn target after raising just $7,000, pharma accused of ‘free‑riding’
The Cali Fund, created to collect $1bn a year from businesses using nature’s genetics for biodiversity conservation, has gathered only $7,000 more than 18 months after launch, prompting criticism of pharmaceutical companies.
3 sources
